Screener
Arcus Biosciences RCUS Business Segments — Interest income, net
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Arcus Biosciences in its filing.
Tagged under the XBRL concept us-gaap:InterestExpenseNonoperating.
The source filing: Arcus Biosciences’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:11 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001724521-26-000044
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Late-stage development programs (1) | 51 | 74 | 111 | 129 |
| Early-stage development and preclinical programs (2) | 21 | 38 | 39 | 80 |
| Compensation and personnel costs | 58 | 61 | 129 | 128 |
| Depreciation and amortization | 2 | 2 | 5 | 5 |
| Interest income, net | (5) | (8) | (11) | (18) |
| Other segment items (3) | 22 | 26 | 40 | 47 |
| Partnership reimbursements | (17) | (33) | (36) | (71) |
| Segment net income (loss) and Consolidated net income (loss) | $(91) | — | $(219) | $(112) |
Item 1. Financial Statements
FAQ
- What is Arcus Biosciences's business segments — interest income, net?
- Arcus Biosciences (RCUS) reported business segments — interest income, net of -$5M in Q2 2026.
- How has Arcus Biosciences's business segments — interest income, net changed year-over-year?
- Arcus Biosciences's business segments — interest income, net increased by 37.5% year-over-year, from -$8M to -$5M.
- What is the long-term trend for Arcus Biosciences's business segments — interest income, net?
- Over 3 years (2022 to 2025), Arcus Biosciences's business segments — interest income, net has grown at a 36.4% compound annual growth rate (CAGR), from -$13M to -$33M.
- What does business segments — interest income, net mean?
- Reflects the net earnings generated from cash and investment balances held by the segment, offset by any interest expenses incurred. It provides insight into the segment's treasury management and the yield on its liquid assets.
Ask your AI about Arcus Biosciences's business segments — interest income, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude